Demant A/S : Unexpected publication of organic growth and EBIT in line with expectations
>Organic growth and operating profit in line as expected - Demant erroneously published organic growth of 27% and operating profit of DKK 3.4bn on its webpage yesterday and sent out a release, which confirmed these numbers this morning. FY 2021 results are scheduled for tomorrow. We looked for 26% organic growth and the consensus for 28%. Expectations for operating profit stood at DKK 3.4bn (ODDO BHF and consensus). We rate these first results as in line with exp...William Demant Holding is a holding company. Through its subsidiaries, Co develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. Co. focuses on four areas: Hearing Devices, Diagnostic Instruments, Hearing Implants and Personal Communication. Co.'s hearing devices include Oticon, Bernafon, Sonic, Phonic Ear, and FrontRow. Co.'s Hearing implant consist of Oticon Medical. Co.'s diagnostic instruments include Maico, Interacoustics, Amplivox, Grason-Stadler, MedRx, and Micromedical. Co.'s personal communication consists of Sennheiser Communications.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.